Stardust Power Confirms No Industrial Wastewater Permit Required for Oklahoma Lithium Facility
GREENWICH, Conn., May 13, 2025 ( GLOBE NEWSWIRE ) -- Stardust Power Inc. ( "Stardust Power" or the "Company" ) , an American developer of battery-grade lithium products, today announced a significant update to its permitting process.
MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers
Post hoc analysis published in the peer-reviewed journal Wounds highlights EscharEx®'s superior clinical performance and comparable safety profile to SANTYL® Post hoc analysis published in the peer-reviewed journal Wounds highlights EscharEx®'s superior clinical performance and comparable safety ...
FAVO Capital Announces Conversion of Super Voting Series C Shares to Common Stock
FORT LAUDERDALE, Fla., May 13, 2025 ( GLOBE NEWSWIRE ) -- via IBN -- FAVO Capital, Inc. ( OTC: FAVO ) , a publicly traded private credit firm specializing in merchant cash advances ( MCAs ) and revenue-based financing for underserved small and medium-sized businesses ( SMBs ) , today announced ...
Bicara Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Updated data from ongoing Phase 1/1b trial in 1L R/M HNSCC to be presented at 2025 ASCO Annual Meeting ...
American Tungsten Corp. To Host Management Update Webinar
Vancouver, BC, May 13, 2025 ( GLOBE NEWSWIRE ) -- American Tungsten Corp. ( CSE:TUNG ) ( OTCQB:DEMRF ) ( FSE:RK9 ) ( "American Tungsten" or the "Company" ) announces that the Company's CEO, Ali Haji will host a webinar to give an overview of the company's recent developments.
First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study
- ATTRibute-CM, BridgeBio's Phase 3 clinical trial of acoramidis in patients with ATTR-CM, achieved statistical significance in reducing the risk of ACM or first CVH versus placebo in ATTRv-CM patients ( 59.1% risk reduction ) , establishing the mechanistic hypothesis that stabilizing TTR may ...
Knight to Present at the 2025 RBC Capital Markets Global Healthcare Conference in New York City
MONTREAL, May 13, 2025 ( GLOBE NEWSWIRE ) -- Knight Therapeutics Inc. ( TSX: GUD ) ( "Knight" ) , a pan-American ( ex-US ) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 2025 RBC ...
Knight to Present at the 2025 RBC Capital Markets Global Healthcare Conference in New York City
MONTREAL, May 13, 2025 ( GLOBE NEWSWIRE ) -- Knight Therapeutics Inc. ( TSX: GUD ) ( "Knight" ) , a pan-American ( ex-US ) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 2025 RBC ...